NCT03123458View on ClinicalTrials.gov

Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders

PHASE1Enrolling by invitationINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 1, 2025

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Immune Related DisorderTissue Damage
Interventions
BIOLOGICAL

clonal fetal MSCs

clonal fetal MSCs

Trial Locations (3)

100020

Capital Institute of Pediatrics affiliated Children's hospital, Beijing

100049

Aerospace Center Hospital, Beijing

518000

Shenzhen Geno-immune Medical Institute, Shenzhen

All Listed Sponsors
lead

Shenzhen Geno-Immune Medical Institute

OTHER